Patents by Inventor Dan Canaani

Dan Canaani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11118182
    Abstract: The invention provides modulators of human cancer and tumor metastasis in particular. More specifically the present disclosure relates to modulators of SKAI1BC, an antisense long non-coding RNA which was found to be an epigenetic suppressor of the metastasis suppressor gene KAI1/CD82, compositions, methods and uses thereof for decreasing metastasis, invasion and possibly also proliferation of cancer cells.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: September 14, 2021
    Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Dan Canaani, Ronni Aram, Iris Dotan, Pnina Gottfried Komlosh
  • Publication number: 20190300884
    Abstract: The invention provides modulators of human cancer and tumor metastasis in particular. More specifically the present disclosure relates to modulators of SKAI1BC, an antisense long non-coding RNA which was found to be an epigenetic suppressor of the metastasis suppressor gene KAI1/CD82, compositions, methods and uses thereof for decreasing metastasis, invasion and possibly also proliferation of cancer cells.
    Type: Application
    Filed: November 16, 2017
    Publication date: October 3, 2019
    Inventors: Dan CANAANI, Ronni ARAM, Iris DOTAN, Pnina GOTTFRIED KOMLOSH
  • Patent number: 6861220
    Abstract: A method for screening molecule which have a synthetic lethal property when in combination with a gene of interest carrying a non-lethal mutation, said method comprising the steps of: transfecting a first reporter gene into mammalian cells having a genome comprising a gene of interest which carries a non-lethal mutation, or a genome which is null of said gene of interest; selecting clones stably expressing said fist reporter gene; introducing into said cells a survival plasmid comprising a functioning copy of said gene of interest, a second reporter gene, selectable marker, an origin of DNA replication and a nuclear antigen gene essential for replication of the plasmid within said cells, wherein said survivsal plasmid is autonomously replicating and spontaneously lost from said cells; growing said cells in the presence of a selection compound which selects for said selectable marker; selecting cell clones stably expressing said second reporter gene and said functioning copy of said gene of interest; removing
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: March 1, 2005
    Assignee: Ramot University Authority for Applied Research & Industrial Development LTD
    Inventors: Dan Canaani, Arnold Simons, Naomi Dafni, Iris Dotan
  • Patent number: 6569623
    Abstract: A screening method which applies the principle of synthetic lethality to a gene of interest in non-yeast eukaryotic cells. The method may be used to screen either a chemical library in order to identify a molecule having a gene-specific lethal property in the cells, or to screen a group of DNA molecules in order to identify among them one or more modulators of gene function which are synergistically lethal to the cells together with an incapacitated gene of interest. Also described are episomal survival plasmids and kits which may be used with the method.
    Type: Grant
    Filed: September 8, 1999
    Date of Patent: May 27, 2003
    Assignee: Ramot University Authority for Applied Research & Industrial Development Ltd.
    Inventors: Dan Canaani, Yoram Oron, Arnold Simons, Naomi Dafni, Iris Dotan
  • Publication number: 20020123034
    Abstract: A method for screening molecule which have a synthetic lethal property when in combination with a gene of interest carrying a non-lethal mutation, said method comprising the steps of: transfecting a first reporter gene into mammalian cells having a genome comprising a gene of interest which carries a non-lethal mutation, or a genome which is null of said gene of interest; selecting clones stably expressing said fist reporter gene; introducing into said cells a survival plasmid comprising a functioning copy of said gene of interest, a second reporter gene, selectable marker, an origin of DNA replication and a nuclear antigen gene essential for replication of the plasmid within said cells, wherein said survivsal plasmid is autonomously replicating and spontaneously lost from said cells; growing said cells in the presence of a selection compound which selects for said selectable marker; selecting cell clones stably expressing said second reporter gene and said functioning copy of said gene of interest; removing
    Type: Application
    Filed: October 12, 2001
    Publication date: September 5, 2002
    Inventors: Dan Canaani, Arnold Simons, Naomi Dafni, Iris Dotan
  • Patent number: 5882880
    Abstract: A novel human radiation protecting checkpoint (RAP-1) gene and the RAP-1 protein encoded by the gene are disclosed. RAP-1 is believed to be involved in the regulation of cell cycle progression and/or programmed cell death (apoptosis). A human antisense RNA which can bind to the mRNA of the human RAP-1 protein, as well as the DNA from which the antisense RNA is transcribed are also disclosed. Additionally, a method for isolating DNA damage-monitoring checkpoint genes is described. The use of the DNA and RNA sequences and of the protein of the invention for the eary detection, prevention and/or treatment of cancer, AIDS and other diseases is also discussed.
    Type: Grant
    Filed: June 11, 1997
    Date of Patent: March 16, 1999
    Assignee: Ramot University Authority for Applied and Industrial Development Ltd.
    Inventor: Dan Canaani